To evaluate the expression and localization of NLGN4X in breast cancer tissues, immunohistochemistry was used to evaluate samples from 60 patients, consisting of adjacent normal tissue (9 patients), breast cancer tissues tumors (40) and respective lymph node metastasis (10). This evidence concerns the gene NLGN4X and metastatic malignant neoplasm in the lymph nodes.